ExploreWatchlistsPricing
  1. US-listed companies
  2. Axsome Therapeutics, Inc.
  3. Financials
  4. Stockholders' equity

Axsome Therapeutics, Inc. (AXSM)

Market cap
$12.1B
P/E ratio
SummaryFinancials
Period EndStockholders' equity (Million USD)YoY (%)
Dec 31, 202588+54.86%
Dec 31, 202457-70.15%
Dec 31, 2023191+74.32%
Dec 31, 2022110+600.92%
Dec 31, 202116-86.26%
Dec 31, 2020114-36.33%
Dec 31, 2019179+18955.16%
Dec 31, 20181-94.39%
Dec 31, 201717-22.50%
Dec 31, 201622

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat